「多發性硬化症患者接種第三劑新冠疫苗的安全性研究」專家意見

Jan 25, 2022 by Science Media Center Taiwan – 議題背景：今（2021）年1月25日，國際期刊《美國醫學會期刊》網路開放版（JAMA Network Open）發表一篇研究。研究指出，已接種過兩劑BNT或莫德納疫苗的130位多發性硬化症患者，再接種第三劑mRNA疫苗後，有病毒棘蛋白專一性的抗體效價增加，且沒有患者產生嚴重的不良反應，最多是注射處疼痛和感到

https://health-desk.org/articles/duo-fa-xing-ying-hua-zheng-huan-zhe-jie-zhong-di-san-ji-xin-guan-yi-miao-de-an-quan-xing-yan-jiu-zhuan-jia-yi-jian

無法取得資料

https://www.tnms.com.tw/msandcovid-19/

A Single-Health System Case Series of New-Onset CNS Inflammatory Disorders Temporally Associated With mRNA-Based SARS-CoV-2 Vaccines

BackgroundSince 2020, over 250 million doses of mRNA-based SARS-CoV-2 vaccines have been administered in the United States and hundreds of millions worldwide between the Pfizer-BioNTech and Moderna SA

https://www.frontiersin.org/articles/10.3389/fneur.2022.796882/full

COVID-19 mRNA vaccination leading to CNS inflammation: a case series - PubMed

The availability of vaccines against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), provides hope towards mitigation of the coronavirus disease 2019 (COVID-19) pandemic. Vaccine saf

https://pubmed.ncbi.nlm.nih.gov/34480607/

不同意見出處

「多發性硬化症患者接種第三劑新冠疫苗的安全性研究」專家意見

A Single-Health System Case Series of New-Onset CNS Inflammatory Disorders Temporally Associated With mRNA-Based SARS-CoV-2 Vaccines

COVID-19 mRNA vaccination leading to CNS inflammation: a case series - PubMed